Loss of PPARγ activity characterizes early protumorigenic stromal reprogramming and dictates the therapeutic window of opportunity
Proceedings of the National Academy of Sciences, Volume 120, Issue 42, October 2023. >>> Read full article>>> Copyright for syndicated ...
Read more
